Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Oct;63(10):4130–4137. doi: 10.1128/iai.63.10.4130-4137.1995

Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides.

J C Garcia-Monco 1, R J Seidman 1, J L Benach 1
PMCID: PMC173580  PMID: 7558329

Abstract

Patients with neuroborreliosis produce antibodies, mostly of the immunoglobulin M (IgM) class, to gangliosides, particularly to those with Gal(beta 1-3)GalNac terminal sequences. Lewis rats were immunized with a nonpathogenic strain of Borrelia burgdorferi and with a chloroform-methanol extract (nonprotein) of this organism (CM) to determine whether antibodies to B. burgdorferi also recognized gangliosides. Rats were also immunized with asialo-GM1 to determine whether the elicited antibodies recognized antigens in B. burgdorferi. Rats immunized with B. burgdorferi produced low levels of IgM antibodies that cross-reacted with asialo-GM1 and GM1. Rats immunized with CM had marked IgM reactivity to asialo-GM1 and GM1. Immunization with asialo-GM1 resulted in antibodies that cross-reacted with B. burgdorferi antigens. Although antibodies to B. burgdorferi were of both the IgM and IgG classes, those to CM and to asialo-GM1 and GM1 were predominantly in the IgM fraction. Reactivity of the IgM antibodies decreased after adsorption with the heterologous and the homologous antigens, indicating bidirectional cross-reactivity between CM, asialo-GM1, and GM1 and that immunization with one produces antibodies to the other. There was no in vivo deposition of Ig in peripheral nerves, nor was there nerve pathology as a result of immunizations, but IgM antibodies to asialo-GM1 and CM recognized homologous antigens in the nodes of Ranvier of peripheral nerves from nonimmunized rats. This immunization model suggests that antibodies to gangliosides in Lyme disease have a microbial origin and are potentially relevant in pathogenesis.

Full Text

The Full Text of this article is available as a PDF (376.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aberer E., Brunner C., Suchanek G., Klade H., Barbour A., Stanek G., Lassmann H. Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol. 1989 Dec;26(6):732–737. doi: 10.1002/ana.410260608. [DOI] [PubMed] [Google Scholar]
  2. Apostolski S., Sadiq S. A., Hays A., Corbo M., Suturkova-Milosevic L., Chaliff P., Stefansson K., LeBaron R. G., Ruoslahti E., Hays A. P. Identification of Gal(beta 1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res. 1994 Jun 1;38(2):134–141. doi: 10.1002/jnr.490380203. [DOI] [PubMed] [Google Scholar]
  3. Aspinall G. O., Fujimoto S., McDonald A. G., Pang H., Kurjanczyk L. A., Penner J. L. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun. 1994 May;62(5):2122–2125. doi: 10.1128/iai.62.5.2122-2125.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beck G., Habicht G. S., Benach J. L., Coleman J. L. Chemical and biologic characterization of a lipopolysaccharide extracted from the Lyme disease spirochete (Borrelia burgdorferi). J Infect Dis. 1985 Jul;152(1):108–117. doi: 10.1093/infdis/152.1.108. [DOI] [PubMed] [Google Scholar]
  5. Belisle J. T., Brandt M. E., Radolf J. D., Norgard M. V. Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins. J Bacteriol. 1994 Apr;176(8):2151–2157. doi: 10.1128/jb.176.8.2151-2157.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Benach J. L., Bosler E. M., Hanrahan J. P., Coleman J. L., Habicht G. S., Bast T. F., Cameron D. J., Ziegler J. L., Barbour A. G., Burgdorfer W. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med. 1983 Mar 31;308(13):740–742. doi: 10.1056/NEJM198303313081302. [DOI] [PubMed] [Google Scholar]
  7. Burgdorfer W., Barbour A. G., Hayes S. F., Benach J. L., Grunwaldt E., Davis J. P. Lyme disease-a tick-borne spirochetosis? Science. 1982 Jun 18;216(4552):1317–1319. doi: 10.1126/science.7043737. [DOI] [PubMed] [Google Scholar]
  8. Corbo M., Quattrini A., Latov N., Hays A. P. Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology. 1993 Apr;43(4):809–814. doi: 10.1212/wnl.43.4.809. [DOI] [PubMed] [Google Scholar]
  9. Eiffert H., Lotter H., Jarecki-Khan K., Thomssen R. Identification of an immunoreactive non-proteinaleous component in Borrelia burgdorferi. Med Microbiol Immunol. 1991;180(5):229–237. doi: 10.1007/BF00202557. [DOI] [PubMed] [Google Scholar]
  10. Enders U., Karch H., Toyka K. V., Michels M., Zielasek J., Pette M., Heesemann J., Hartung H. P. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol. 1993 Aug;34(2):136–144. doi: 10.1002/ana.410340208. [DOI] [PubMed] [Google Scholar]
  11. Endo T., Scott D. D., Stewart S. S., Kundu S. K., Marcus D. M. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol. 1984 Apr;132(4):1793–1797. [PubMed] [Google Scholar]
  12. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  13. Fikrig E., Berland R., Chen M., Williams S., Sigal L. H., Flavell R. A. Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):183–187. doi: 10.1073/pnas.90.1.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Garcia Monco J. C., Fernandez Villar B., Rogers R. C., Szczepanski A., Wheeler C. M., Benach J. L. Borrelia burgdorferi and other related spirochetes bind to galactocerebroside. Neurology. 1992 Jul;42(7):1341–1348. doi: 10.1212/wnl.42.7.1341. [DOI] [PubMed] [Google Scholar]
  15. Garcia-Monco J. C., Benach J. L. Lyme neuroborreliosis. Ann Neurol. 1995 Jun;37(6):691–702. doi: 10.1002/ana.410370602. [DOI] [PubMed] [Google Scholar]
  16. Garcia-Monco J. C., Coleman J. L., Benach J. L. Antibodies to myelin basic protein in Lyme disease. J Infect Dis. 1988 Sep;158(3):667–668. doi: 10.1093/infdis/158.3.667. [DOI] [PubMed] [Google Scholar]
  17. Garcia-Monco J. C., Fernandez Villar B., Szczepanski A., Benach J. L. Cytotoxicity of Borrelia burgdorferi for cultured rat glial cells. J Infect Dis. 1991 Jun;163(6):1362–1366. doi: 10.1093/infdis/163.6.1362. [DOI] [PubMed] [Google Scholar]
  18. Garcia-Monco J. C., Fernandez-Villar B., Benach J. L. Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J Infect Dis. 1989 Sep;160(3):497–506. doi: 10.1093/infdis/160.3.497. [DOI] [PubMed] [Google Scholar]
  19. Garcia-Monco J. C., Villar B. F., Alen J. C., Benach J. L. Borrelia burgdorferi in the central nervous system: experimental and clinical evidence for early invasion. J Infect Dis. 1990 Jun;161(6):1187–1193. doi: 10.1093/infdis/161.6.1187. [DOI] [PubMed] [Google Scholar]
  20. García Moncó J. C., Wheeler C. M., Benach J. L., Furie R. A., Lukehart S. A., Stanek G., Steere A. C. Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides. J Neurol Sci. 1993 Jul;117(1-2):206–214. doi: 10.1016/0022-510x(93)90175-x. [DOI] [PubMed] [Google Scholar]
  21. Habicht G. S., Katona L. I., Benach J. L. Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J Infect Dis. 1991 Sep;164(3):568–574. doi: 10.1093/infdis/164.3.568. [DOI] [PubMed] [Google Scholar]
  22. Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem. 1990 Nov 5;265(31):18713–18716. [PubMed] [Google Scholar]
  23. Halperin J. J., Kaplan G. P., Brazinsky S., Tsai T. F., Cheng T., Ironside A., Wu P., Delfiner J., Golightly M., Brown R. H. Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch Neurol. 1990 May;47(5):586–594. doi: 10.1001/archneur.1990.00530050110021. [DOI] [PubMed] [Google Scholar]
  24. Halperin J., Luft B. J., Volkman D. J., Dattwyler R. J. Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain. 1990 Aug;113(Pt 4):1207–1221. doi: 10.1093/brain/113.4.1207. [DOI] [PubMed] [Google Scholar]
  25. Hirabayashi Y., Suzuki T., Suzuki Y., Taki T., Matsumoto M., Higashi H., Kato S. A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. J Biochem. 1983 Jul;94(1):327–330. doi: 10.1093/oxfordjournals.jbchem.a134350. [DOI] [PubMed] [Google Scholar]
  26. Ilyas A. A., Willison H. J., Quarles R. H., Jungalwala F. B., Cornblath D. R., Trapp B. D., Griffin D. E., Griffin J. W., McKhann G. M. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol. 1988 May;23(5):440–447. doi: 10.1002/ana.410230503. [DOI] [PubMed] [Google Scholar]
  27. Kuroki S., Saida T., Nukina M., Haruta T., Yoshioka M., Kobayashi Y., Nakanishi H. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol. 1993 Mar;33(3):243–247. doi: 10.1002/ana.410330304. [DOI] [PubMed] [Google Scholar]
  28. Ma Y., Weis J. J. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun. 1993 Sep;61(9):3843–3853. doi: 10.1128/iai.61.9.3843-3853.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Martin R., Ortlauf J., Sticht-Groh V., Bogdahn U., Goldmann S. F., Mertens H. G. Borrelia burgdorferi--specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis. Ann Neurol. 1988 Oct;24(4):509–516. doi: 10.1002/ana.410240406. [DOI] [PubMed] [Google Scholar]
  30. Mishu B., Blaser M. J. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis. 1993 Jul;17(1):104–108. doi: 10.1093/clinids/17.1.104. [DOI] [PubMed] [Google Scholar]
  31. Mishu B., Ilyas A. A., Koski C. L., Vriesendorp F., Cook S. D., Mithen F. A., Blaser M. J. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med. 1993 Jun 15;118(12):947–953. doi: 10.7326/0003-4819-118-12-199306150-00006. [DOI] [PubMed] [Google Scholar]
  32. Pachner A. R., Itano A. Borrelia burgdorferi infection of the brain: characterization of the organism and response to antibiotics and immune sera in the mouse model. Neurology. 1990 Oct;40(10):1535–1540. doi: 10.1212/wnl.40.10.1535. [DOI] [PubMed] [Google Scholar]
  33. Pestronk A., Adams R. N., Clawson L., Cornblath D., Kuncl R. W., Griffin D., Drachman D. B. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology. 1988 Sep;38(9):1457–1461. doi: 10.1212/wnl.38.9.1457. [DOI] [PubMed] [Google Scholar]
  34. Pestronk A., Chaudhry V., Feldman E. L., Griffin J. W., Cornblath D. R., Denys E. H., Glasberg M., Kuncl R. W., Olney R. K., Yee W. C. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol. 1990 Mar;27(3):316–326. doi: 10.1002/ana.410270314. [DOI] [PubMed] [Google Scholar]
  35. Quarles R. H., Ilyas A. A., Willison H. J. Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome. Ann Neurol. 1990;27 (Suppl):S48–S52. doi: 10.1002/ana.410270713. [DOI] [PubMed] [Google Scholar]
  36. Radolf J. D., Arndt L. L., Akins D. R., Curetty L. L., Levi M. E., Shen Y., Davis L. S., Norgard M. V. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol. 1995 Mar 15;154(6):2866–2877. [PubMed] [Google Scholar]
  37. Salazar-Grueso E. F., Routbort M. J., Martin J., Dawson G., Roos R. P. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol. 1990 May;27(5):558–563. doi: 10.1002/ana.410270517. [DOI] [PubMed] [Google Scholar]
  38. Santoro M., Thomas F. P., Fink M. E., Lange D. J., Uncini A., Wadia N. H., Latov N., Hays A. P. IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block. Ann Neurol. 1990 Sep;28(3):373–377. doi: 10.1002/ana.410280312. [DOI] [PubMed] [Google Scholar]
  39. Schwerer B., Lassmann H., Kitz K., Bernheimer H. Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol. 1986;72(1):55–61. doi: 10.1007/BF00687947. [DOI] [PubMed] [Google Scholar]
  40. Sigal L. H., Tatum A. H. Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology. 1988 Sep;38(9):1439–1442. doi: 10.1212/wnl.38.9.1439. [DOI] [PubMed] [Google Scholar]
  41. Steere A. C., Grodzicki R. L., Kornblatt A. N., Craft J. E., Barbour A. G., Burgdorfer W., Schmid G. P., Johnson E., Malawista S. E. The spirochetal etiology of Lyme disease. N Engl J Med. 1983 Mar 31;308(13):733–740. doi: 10.1056/NEJM198303313081301. [DOI] [PubMed] [Google Scholar]
  42. Steere A. C. Lyme disease. N Engl J Med. 1989 Aug 31;321(9):586–596. doi: 10.1056/NEJM198908313210906. [DOI] [PubMed] [Google Scholar]
  43. Streit W. J., Schulte B. A., Spicer S. S., Balentine J. D. Histochemical localization of galactose-containing glycoconjugate at peripheral nodes of Ranvier in the rat. J Histochem Cytochem. 1985 Jan;33(1):33–39. doi: 10.1177/33.1.2578143. [DOI] [PubMed] [Google Scholar]
  44. Suchanek G., Kristoferitsch W., Stanek G., Bernheimer H. Anti-myelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth and other neurological diseases. Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Dec;263(1-2):160–168. doi: 10.1016/s0176-6724(86)80119-5. [DOI] [PubMed] [Google Scholar]
  45. Takayama K., Rothenberg R. J., Barbour A. G. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun. 1987 Sep;55(9):2311–2313. doi: 10.1128/iai.55.9.2311-2313.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Thomas D. D., Cadavid D., Barbour A. G. Differential association of Borrelia species with cultured neural cells. J Infect Dis. 1994 Feb;169(2):445–448. doi: 10.1093/infdis/169.2.445. [DOI] [PubMed] [Google Scholar]
  47. Thomas F. P., Lee A. M., Romas S. N., Latov N. Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins. J Neuroimmunol. 1989 Jul;23(2):167–174. doi: 10.1016/0165-5728(89)90036-2. [DOI] [PubMed] [Google Scholar]
  48. Thomas F. P., Trojaborg W., Nagy C., Santoro M., Sadiq S. A., Latov N., Hays A. P. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol. 1991;82(5):378–383. doi: 10.1007/BF00296548. [DOI] [PubMed] [Google Scholar]
  49. Vriesendorp F. J., Mishu B., Blaser M. J., Koski C. L. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol. 1993 Aug;34(2):130–135. doi: 10.1002/ana.410340206. [DOI] [PubMed] [Google Scholar]
  50. Weller M., Stevens A., Sommer N., Dichgans J., Kappler B., Wiethölter H. Ganglioside antibodies: a lack of diagnostic specificity and clinical utility? J Neurol. 1992 Oct;239(8):455–459. doi: 10.1007/BF00856811. [DOI] [PubMed] [Google Scholar]
  51. Weller M., Stevens A., Sommer N., Wiethölter H. Are CSF or serum ganglioside antibodies related to peripheral nerve demyelination in neuroborreliosis, Guillain-Barré syndrome, or chronic inflammatory demyelinating polyradiculoneuropathy? Eur Arch Psychiatry Clin Neurosci. 1992;242(2-3):122–126. doi: 10.1007/BF02191559. [DOI] [PubMed] [Google Scholar]
  52. Weller M., Stevens A., Sommer N., Wiethölter H., Dichgans J. Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis. Arch Neurol. 1991 Aug;48(8):837–841. doi: 10.1001/archneur.1991.00530200079022. [DOI] [PubMed] [Google Scholar]
  53. Wheeler C. M., Garcia Monco J. C., Benach J. L., Golightly M. G., Habicht G. S., Steere A. C. Nonprotein antigens of Borrelia burgdorferi. J Infect Dis. 1993 Mar;167(3):665–674. doi: 10.1093/infdis/167.3.665. [DOI] [PubMed] [Google Scholar]
  54. Wirguin I., Suturkova-Milosevic L., Della-Latta P., Fisher T., Brown R. H., Jr, Latov N. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann Neurol. 1994 Jun;35(6):698–703. doi: 10.1002/ana.410350610. [DOI] [PubMed] [Google Scholar]
  55. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993 Nov 1;178(5):1771–1775. doi: 10.1084/jem.178.5.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Yuki N., Yoshino H., Sato S., Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 1990 Dec;40(12):1900–1902. doi: 10.1212/wnl.40.12.1900. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES